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Abstract. Deep learning approaches such as convolutional neural nets
have consistently outperformed previous methods on challenging tasks
such as dense, semantic segmentation. However, the various proposed
networks perform differently, with behaviour largely influenced by ar-
chitectural choices and training settings. This paper explores Ensembles
of Multiple Models and Architectures (EMMA) for robust performance
through aggregation of predictions from a wide range of methods. The ap-
proach reduces the influence of the meta-parameters of individual mod-
els and the risk of overfitting the configuration to a particular database.
EMMA can be seen as an unbiased, generic deep learning model which
is shown to yield excellent performance, winning the first position in the
BRATS 2017 competition among 50+ participating teams.
1 Introduction
Brain tumours are among the most fatal types of cancer [1]. Out of tumours that
originally develop in the brain, gliomas are the most frequent [2]. They arise from
glioma cells and, depending on their aggressiveness, they are broadly categorized
into high and low grade gliomas [3]. High grade gliomas (HGG) develop rapidly
and aggressively, forming abnormal vessels and often a necrotic core, accompa-
nied by surrounding oedema and swelling [2]. They are malignant, with high
mortality and average survival rate of less than two years even after treatment
[3]. Low grade gliomas (LGG) can be benign or malignant, grow slower, but they
may recur and evolve to HGG, thus their treatment is warranted. For treatment,
patients undergo radiotherapy, chemotherapy and surgery [1].
Firstly for diagnosis and monitoring the tumour’s progression, then for treat-
ment planning and afterwards for assessing the effect of treatment, various neuro-
imaging protocols are employed. Magnetic resonance imaging (MRI) is widely
used in both clinical routine and research studies. It facilitates tumour analysis
by allowing estimation of extent, location and investigation of its subcomponents
[2]. This however requires accurate delineation of the tumour, which proves chal-
lenging due to its complex structure and appearance, the 3D nature of the MR
images and the multiple MR sequences that need to be consulted in parallel for
informed judgement. These factors make manual delineation time-consuming
and subject to inter- and intra-rater variability [4].
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Fig. 1: Left to right: FLAIR; manual annotation of a BRATS’17 subject, where
yellow depicts oedema surrounding tumour core; confidence of a CNN predicting
oedema, trained with cross-entropy or IoU loss. Although overall performance is
similar, training with IoU (or Dice, not shown) loss alters the CNN’s behaviour,
which tends to output only highly confident predictions, even when false.
Automatic segmentation systems aim at providing an objective and scalable
solution. Representative early works are the atlas-based outlier detection method
[5] and the joint segmentation-registration framework, often guided by a tumour
growth model [6,7,8]. The past few years saw rapid developments of machine
learning methods, with Random Forests being among the most successful [9,10].
More recently, convolutional neural networks (CNN) have gained popularity by
exhibiting very promising results for segmentation of brain tumours [11,12,13].
A variety of CNN architectures have been proposed, each presenting different
strengths and weaknesses. Additionally, networks have a vast number of meta
parameters. The multiple configuration choices for a system influence not only
performance but also its behaviour (Fig. 1). For instance, different models may
perform better with different types of pre-processing. Consequently, when in-
vestigating their behaviour on a given task, findings can be biased. Finally, a
configuration highly optimized on a given database may be an over-fit, and not
generalise to other data or tasks.
In this work we push towards constructing a more reliable and objective deep
learning model. We bring together a variety of CNN architectures, configured
and trained in diverse ways in order to introduce high variance between them. By
combining them, we construct an Ensemble of Multiple Models and Architectures
(EMMA), with the aim of averaging away the variance and with it model- and
configuration-specific behaviours. Our approach leads to: (1) a system robust to
unpredictable failures of independent components, (2) enables objective analysis
with a generic deep learning model of unbiased behaviour, (3) introduces the
new perspective of ensembling for objectiveness. This is in contrast to common
ensembles, where a single model is trained with small variations such as initial
seeds, which renders the ensemble biased by the main architectural choices. As
a first milestone in this endeavour, we evaluated EMMA in the Brain Tumour
Segmentation (BRATS) challenge 2017. Our method won the first position in
the final testing stage among 50+ competing teams. This indicates the reliability
of the approach and paves the way for its use in further analysis.
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2 Background: Model bias, variance and ensembling
Feedforward neural networks have been shown capable of approximating any
function [14]. They are thus models with zero bias, possible of no systematic
error. However they are not a panacea. If left unregularized they can overfit noise
in the training data, which leads to mistakes when they are called to generalise.
Coupled with the stochasticity of the optimization process and the multiple
local minima, this leads to unpredictable inconsistent errors between different
instances. This constitutes models with high variance. Regularization reduces the
variance but increases the bias, as expressed in the bias/variance dilemma [15].
Regularization can be explicit, such as weight decay that prevents networks from
learning rare noisy patterns, or implicit, such as the local connectivity of CNN
kernels, which however does not allow the model to learn patterns larger than
the its receptive field. Architectural and configuration choices thus introduce
bias, altering the behaviour of a network.
One route to address the bias/variance dilemma is ensembling. By combining
multiple models, ensembling seeks to create a higher performing model with low
variance. The most popular combination rule is averaging, which is not sensitive
to inconsistent errors of the singletons [16]. Commonly, instances of a network
trained with different initial weights or from multiple final local minima are
ensembled, with the majority correcting irregular errors. Intuitively, only incon-
sistent errors can be averaged out. Lack of consistent failures can be interpreted
as statistical independency. Thus methods for de-correlating the instances have
been developed. The most popular is bagging [17], commonly used for random
forests. It uses bootstrap sampling to learn less correlated instances from differ-
ent subsets of the data.
The above works often discuss ensembling as a means of increasing per-
formance. [18] approached high variance from the scope of unreliability. They
discussed ensembling as a type of N-version programming, which advocates reli-
ability through redundancy. When producing N-versions of a program, versions
may fail independently but through majority voting they behave as a reliable
system. They formalize intuitive requirements for reliability: a) the target func-
tion to be covered by the ensemble and b) the majority to be correct. This in
turn advocates diversity, independence and overall quality of the components.
Biomedical applications are reliability-critical and high variance would deter
the use of neural networks. For this reason we set off to investigate robustness
of diverse ensembles. Diverting from the above works, we introduce another
perspective of ensembling: creating an objective, configuration-invariant model
to facilitate objective analysis.
3 Ensembles of Multiple Models and Architectures
A variety of CNN architectures has shown promising results in recent literature.
Regarding the architectures, they commonly differ in depth, number of filters and
how they process multi-scale context among others. Such architectural choices
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Fig. 2: Our ensemble of diverse networks, EMMA (red), averages out the bias
infused by individual model configurations m, to approximate more reliably the
true posterior (black), while being robust to suboptimal configurations. Poste-
riors on the left were obtained from multiple perceptrons, trained to classify
clusters centred on 10 and -10 as a toy example, with different losses, regulariza-
tions and noise in the training labels. Their ensemble provides reliable estimates.
bias the model behaviour. For instance, models with large receptive fields may
show improved localisation capabilities but can be less sensitive to fine texture
than models emphasizing local information. Strategies to handle class imbal-
ance is another performance relevant parameter. Common strategies are train-
ing with class-weighted sampling or class-weighted cross entropy. As analysed in
[13], these methods strongly influence the sensitivity of the model to each class.
Furthermore, the choice of the loss function impacts results. For example, we
observed that networks trained to optimize Intersection over Union (IoU), Dice
or similar losses [19] tend to give worse confidence estimations than when trained
with cross entropy (Fig. 1). Finally, the setting of hyper-parameters for the op-
timization can strongly affect performance. It is often observed by practitioners
that the choice of the optimizer and its configuration, for instance the learning
rate schedule, can make the difference between bad and good segmentation.
The sensitivity to such meta-parameters is a greater problem than merely a
time-consuming manual optimization of configurations:
– A configuration setting optimized on one set of training data may be over-
fitting them and not perform well on unseen data or another task. This can
be viewed as another source of high model variance (Sec. 2).
– By biasing the behaviour of the model, it also biases the findings of any
analysis performed with it.
We now formalize the problem and our perspective of ensembling as a solution
as follows. Given training data X with labels Y , we need to learn the generating
process P (y|x). This is commonly approximated by a model P (y|x; θm,m), which
has trainable parameters θm that are learnt via an optimization process that
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minimizes:
θm = min
θm
d(P (Y |X; θm,m), P (Y |X)) (1)
where d is a distance (defined by the type of loss) computed at the points given
by the training data, while m represents the choice of the meta-parameters. It
is commonly neglected although it conditions (biases) the learnt estimator. To
take it into account, we instead define m as a stochastic variable over the space
of meta-parameter configurations, with a corresponding prior P (m). In order to
learn a model of P (y|x) unbiased by m, we marginalize out its effect:
P (y|x) =
∑
m
P (y,m|x) =
∑
m
P (y|x,m)P (m)
≈
∑
∀m∈E
P (y|x; θm,m) 1|E| = PEMMA(y|x)
(2)
Here E is the set of models within the ensemble. The prior P (m) is considered
uniform over a subspace of m that is covered by the models in E and zero
elsewhere. Note we have arrived at the standard ensembling with averaging, by
considering that each individual model P (y|x; θm,m) approximates a conditional
P (y|x,m) on m, and the true posterior is approximated by the ensemble which
marginalizes away effects of m. Note that the case of a single model configured
by m can be derived from the above, by setting a dirac prior P (m) = δ(m).
Thus the ensemble relaxes a pre-existing neglected strong prior.
The above formulation presents averaging ensembles from a new perspective:
The marginalization over a subspace of the joint P (y|x,m) offers generalisation,
regularising the (manual) optimization process of m from falling into minima
where P (Y |X,m) overfits P (Y |X) on the given training data (Y,X) (Fig. 2).
Moreover, the process leads to a more objective approximation of P (y|x) where
the biasing effect of m has been marginalized out. The exposed limitations agree
with the requirements for ensembling mentioned in Sec. 2: we need to restrict
the subspace of m into an area of relatively high quality models and we need to
cover it with a relatively small number of models, thus diversity is key.
In the remainder of this section we describe the main properties of the models
used to construct the collection E of EMMA, which cover various contemporary
architectures, configured and trained under different settings1.
3.1 DeepMedic
Model description: The first architecture we employ is DeepMedic, originally
presented in [20,13]. It is a fully 3D, multi-scale CNN, designed with a focus
on efficient processing of 3D images. For this, it employs parallel pathways that
take as input down-sampled context, avoiding to convolve large volumes at full
resolution to remain computationally cheap. Although originally developed for
1 Implementation and configuration details considered less important for this work
were omitted to avoid cluttering the manuscript.
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Fig. 3: We used two DeepMedics [13] in our experiments. The smaller of the two
is depicted, where the number of feature maps and their dimension at every
layer are depicted in the format (Number × Size). The second model used in
the ensemble is wider, with double the number of feature maps at every layer.
All kernels and feature maps are 3D, even though not depicted for simplicity.
segmentating brain lesions, it was found promising on diverse tasks, such as
segmentation of the placenta [21], making it a good component for a robust
ensemble. We include two deepMedic models in EMMA. The first is the residual
version previously employed in BRATS 2016 [22], depicted in Fig. 3. The second
is a wider variant, with double the number of feature maps at each layer.
Training details: The models are trained by extracting multi-scale image seg-
ments with a 50% probability centred on healthy tissue and 50% probability on
tumour as proposed in [13]. The wider variant is trained on larger inputs of width
34 and 22 for the two scales respectively. They are trained with cross-entropy
loss, with all meta-parameters adopted from the original configuration.
3.2 FCN
Model description: We integrate three 3D FCNs [23] in EMMA. A schematic of
the first architecture is depicted in Fig. 4. The second FCN is constructed larger,
replacing each convolutional layer with a residual block with two convolutions.
The third is also residual-based, but with one less down-sampling step. All layers
use batch normalisation, ReLUs and zero-padding.
Training details: We draw training patches of width 64 for the first and 80 voxels
for the residual-based FCNs, with an equal probability from each label. They
were trained using Adam. The first was trained to optimize the IoU loss [19]
while the Dice was used similarly for the other two.
3.3 U-Net
Model description: We employ two 3D versions of the U-Net architecture [24] in
our ensemble. The main elements of the first architecture are depicted in Fig. 5.
In this version we follow the strategy suggested in [25] to reduce model complex-
ity, where skip connections are implemented via summations of the signals in the
up-sampling part of the network, instead of the concatenation originally used.
The second architecture is similar but concatenates the skip connections and uses
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Fig. 4: Schematic of one of the FCN architecture used in EMMA. Shown are
number of feature maps per layer. All kernels and feature maps are 3D, even
though not depicted for simplicity.
Fig. 5: Schematic of an adapted Unet used in our experiments. Depicted are
number of feature maps per layer. All kernels and feature maps are 3D, even
though not depicted for simplicity.
strided convolutions instead of max pooling. All layers use batch normalisation,
ReLUs and zero-padding.
Training Details: The U-Nets were trained with input patches of size 64×64×64.
The patches were sampled only from within the brain, with equal probability
being centred around a voxel from each of the four labels. They were trained
minimizing cross entropy via AdaDelta and Adam respectively, with different
optimization, regularization and augmentation meta-parameters.
3.4 Ensembling
The above models are all trained completely separately. At testing time, each
model segments individually an unseen image and outputs its class-confidence
maps. The models are then ensembled into EMMA, according to eq. 2. For this,
the ensemble’s confidence maps for each class are created by calculating for each
voxel the average confidence of the individual models for the voxel to belong to
this class. The final segmentation made by the EMMA is performed by assigning
to each voxel the class with the highest confidence.
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3.5 Implementation details
The original implementation of DeepMedic was used for the corresponding two
models, along with the default meta-parameters, publicly available on https://
biomedia.doc.ic.ac.uk/software/deepmedic/. The FCNs were implemented
using DLTK, a deep learning library with a focus on medical imaging applications
that allowed quick implementation and experimentation (https://github.com/
DLTK/DLTK). Finally, an adaptation of the Unet will be released on https://
gitlab.com/eferrante.
4 Evaluation
4.1 Material
Our system was evaluated on the data from the Brain Tumour Segmentation
Challenge 2017 (BRATS) [4,26,27,28]. The training set consists of 210 cases with
high grade glioma (HGG) and 75 cases with low grade glioma (LGG), for which
manual segmentations are provided. The segmentations include the following
tumour tissue labels: 1) necrotic core and non enhancing tumour, 2) oedema, 4)
enhancing core. Label 3 is not used. The validation set consists of 46 cases, both
HGG and LGG but the grade is not revealed. Reference segmentations for the
validation set are hidden and evaluation is carried out via an online system that
allows multiple submissions. In the testing phase of the competition, a test set
of 146 cases is provided to the teams, and the teams have a 48 hours window
for a single submission to the system. For evaluation, the 3 predicted labels
are merged into different sets of whole tumour (all labels), the core (labels 1,4)
and the enhancing tumour (label 4). For each subject, four MRI sequences are
available, FLAIR, T1, T1 contrast enhanced (T1ce) and T2. The datasets are
pre-processed by the organisers and provided as skull-stripped, registered to a
common space and resampled to isotropic 1mm3 resolution. Dimensions of each
volume are 240× 240× 155.
4.2 Preprocessing: Ensembling intensity normalisation methods
We experimented with three different versions of intensity normalisation as pre-
processing: 1) Z-score normalisation of each modality of each case individually,
with the mean and stdev of the brain intensities. 2) Bias field correction followed
by (1). 3) Bias field correction, followed by piece-wise linear normalisation [29],
followed by (1). Preliminary comparisons were inconclusive. We instead chose
to average away the normalisation’s effect with EMMA. Three instances of each
network were trained, each on data processed with different normalisation. They
were applied to correspondingly processed images for inference and all results
were averaged in EMMA (Fig. 6).
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Fig. 6: Results are affected by normalization. To make a system robust to this
factor, we introduce in EMMA models trained on differently normalized data.
4.3 Results
We provide the results that EMMA achieved on the validation and testing set
of the BRATS’17 challenge2 on Table 1. Our system won the competition by
achieving the overall best performance in the testing phase, based on Dice score
(DSC) and Haussdorf distance. We also show results achieved on the validation
set by the teams that ranked in the next two positions at the testing stage.
No testing-phase metrics are available to us for these methods. We note that
EMMA achieves similar levels of performance on validation and test sets, even
though the latter contains data from different sources, indicating the robustness
of the method. In comparison, competing methods were very good fits for the
validation set, but did not manage to retain the same levels on the testing set.
This emphasizes the importance of research towards robust and reliable systems.
Table 1: Performance of EMMA on the validation and test sets of BRATS 2017
(submission id biomedia1). Our system achieved the top segmentation perfor-
mance in the testing stage of the competition. For comparison we show the
performance on validation set of the teams that ranked in the next two position.
Performance of other teams in the testing stage is not available to us.
DSC Sensitivity Hausdorff 95
Enh. Whole Core Enh. Whole Core Enh. Whole Core #submits
EMMA (val) 73.8 90.1 79.7 78.3 89.5 76.2 4.50 4.23 6.56 2
UCL-TIG (val) 78.6 90.5 83.8 77.1 91.5 82.2 3.28 3.89 6.48 21
MIC DKFZ (val) 73.2 89.6 79.7 79.0 89.6 78.1 4.55 6.97 9.48 2
EMMA (test) 72.9 88.6 78.5 - - - 36.0 5.01 23.1 1
2 Leaderboard: https://www.cbica.upenn.edu/BraTS17/lboardValidation.html
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Fig. 7: FLAIR, T1ce and manual annotation of a case in the training set, along
with automatic segmentation from preliminary version of EMMA consisting of
six models. Green arrows point inconsistent mistakes by the individual model
that are corrected by the ensembling, while red arrow shows a consistent mistake.
5 Conclusion
Neural networks have been proven very potent, yet imperfect estimators, often
making unpredictable errors. Biomedical applications are reliability-critical how-
ever. For this reason we first concentrate on improving robustness. Towards this
goal we introduced EMMA, an ensemble of widely varying CNNs. By combining
a heterogeneous collection of networks we construct a model that is insensitive
to independent failures of CNN components and thus generalises well (Fig. 7).
We also introduced the new perspective of ensembling for objectiveness. By
marginalizing out via ensembling the biased behaviour introduced by configura-
tion choices, EMMA is a model more fit for objective analysis. Even though the
individual networks have straight-forward architectures and were not optimized
for the task, EMMA won the first position in the final testing stage of BRATS
2017 competition among 50+ teams, indicating strong generalisation.
By being robust to suboptimal configurations of its components, EMMA
may offer re-usability on different tasks, which we aim to explore in the future.
EMMA could also be useful in unbiased investigation of factors such as sensitivity
of CNNs to different sources of domain shift that is strongly affecting large-scale
studies [30], or estimating amount of training data required for a task. Finally,
EMMA’s uncertainty could serve as a more objective measure of what type of
patients or tumours are most challenging to learn.
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